Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.69%
1,068.24
-29.57
-2.69%
—1,097.811,087.761,087.761,067.42——
SIXC
Communications
SIXC
Communications
SIXC
-0.89%
606.59
-5.44
-0.89%
—612.03612.03612.03606.13——
SIXE
Energy
SIXE
Energy
SIXE
+2.19%
1,247.21
+26.78
+2.19%
—1,220.431,221.991,247.601,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.82%
1,727.58
-31.94
-1.82%
—1,759.521,754.311,754.311,723.60——
SIXM
Financials
SIXM
Financials
SIXM
-0.32%
629.54
-2.00
-0.32%
—631.54631.27633.99628.63——
SIXR
Staples
SIXR
Staples
SIXR
-0.42%
853.60
-3.56
-0.42%
—857.16858.91861.71852.33——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.56%
212.04
-3.37
-1.56%
—215.41215.41215.41211.88——
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,549.76
-64.39
-1.78%
—3,614.153,556.243,598.363,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-2.40%
886.49
-21.81
-2.40%
—908.30906.55906.55885.88——
SIXV
Health care
SIXV
Health care
SIXV
-1.08%
1,464.34
-16.06
-1.08%
—1,480.401,479.551,484.431,462.52——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.84%
2,354.25
-44.12
-1.84%
—2,398.372,373.092,373.092,350.27——
PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$1.98
-1.00%
(-0.020) 1D
$2.08
+5.05% (+0.100)
After hours
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLX...
Open
$2.00
High
$2.04
Low
$1.95
Mkt. cap
159.53M
Avg. vol.
755.56K
Volume
1.10M
52-wk high
$3.19
52-wk low
$1.32
EPS
-$0.08
Beta
-0.01
Shares outstanding
80.57M
No. of employees
226
News stories
From sources across the web
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.66M
17.85M
9.12M
33.75M
Cost of goods sold
5.87M
8.32M
23.51M
4.13M
Cost of revenue
5.87M
8.32M
23.51M
4.13M
Research and development expenses
5.99M
4.47M
-13.25M
5.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62M
2.93M
3.53M
3.05M
Operating expense
8.62M
7.40M
-9.73M
8.48M
Total operating expenses
14.49M
15.72M
13.78M
12.60M
Operating income
1.17M
2.13M
-4.66M
21.15M
Other non operating income
-
-
-
-
EBT including unusual items
661.00K
2.24M
-4.78M
21.14M
EBT excluding unusual items
661.00K
2.24M
-4.78M
21.14M
Income tax expense
497.00K
-116.00K
728.00K
2.82M
Effective tax rate
75.19%
-5.18%
-15.24%
13.36%
Other operating expenses
-
-
-
-
Net income
164.00K
2.36M
-5.50M
18.32M
Net profit margin
1.05%
13.19%
-60.34%
54.27%
Earnings per share
-
-
-
-
Interest and investment income
272.00K
288.00K
265.00K
188.00K
Interest expense
-783.00K
-180.00K
-383.00K
-193.00K
Net interest expenses
-511.00K
108.00K
-118.00K
-5.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.53M
2.50M
-4.27M
21.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer